Arlington, MA, United States of America

Elena Kostik

USPTO Granted Patents = 28 


 

Average Co-Inventor Count = 5.8

ph-index = 12

Forward Citations = 325(Granted Patents)


Company Filing History:


Years Active: 2004-2015

Loading Chart...
Loading Chart...
Loading Chart...
28 patents (USPTO):Explore Patents

Title: **Elena Kostik: A Trailblazer in Pharmaceutical Innovations**

Introduction

Elena Kostik, based in Arlington, MA, is a prolific inventor with an impressive portfolio of 28 patents. Her work primarily focuses on pharmaceutical compositions and compounds aimed at modulating critical biological processes, particularly in the context of treating serious conditions such as cancer.

Latest Patents

Among her latest innovations, one notable patent is for triazole compounds that modulate HSP90 activity. This invention encompasses a range of substituted triazole compounds and their formulations designed to inhibit HSP90 in individuals diagnosed with hyperproliferative disorders, including cancer. The application highlights not only the compounds themselves but also various methods for administering these substances to affected subjects.

Another significant patent involves polymorphs of N-malonyl-bis(N'-methyl-N'-thiobenzoylhydrazide). This patent specifies that at least 70% by weight of the compound exists in certain crystalline forms, which are pivotal for its pharmaceutical applications. The inventions also include methods for treating cancer by using these compounds effectively, showcasing Kostik's commitment to advancing cancer treatment strategies.

Career Highlights

Elena Kostik works at Synta Pharmaceuticals Corporation, where she applies her expertise in pharmacology and medicinal chemistry to develop innovative therapeutic solutions. Her dedication to research and development has made her a prominent figure in the pharmaceutical industry, continually striving to bridge the gap between laboratory discoveries and clinical applications.

Collaborations

Throughout her career, Kostik has collaborated with notable peers, including Lijun Sun and Teresa Przewloka. This teamwork further amplifies her contributions to the field and underscores the importance of collaboration in advancing complex scientific endeavors.

Conclusion

With her 28 patents and ongoing contributions to the field, Elena Kostik exemplifies the essence of innovation in pharmaceutical science. Her work not only aids in the fight against cancer but also reflects her commitment to improving patient outcomes through groundbreaking research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…